We want to investigate the effects of pioglitazone on cardiovascular events in Japanese patients with type 2 diabetes.
Primary composite endpoints:
Cardiovascular death Non-fatal myocardial infarction and angina Non-fatal stroke Renal failure (hemodialysis/doubling of serum creatinine)
Secondary endpoints:
urinary albumin excretion diabetic retinopathy hyperlipidemia hypertension gout
Inclusion Criteria:
Exclusion Criteria: